Benzinga | Oct 21, 2021 12:10PM EDT

Caribou Biosciences To Present At Jefferies Summit On Wednesday, Oct. 27 At 1 p.m. EDT, At Barclays Summit Monday, Nov. 15, 9:30 a.m. EDT

Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel Haurwitz, Ph.D., Caribou's President and Chief Executive Officer, will present a company overview at the following upcoming investor conferences.

* Jefferies Gene Therapy/Editing Summit: Wednesday, October 27, 1:00-1:25 PM ET

* Barclays Gene Editing & Gene Therapy Summit: Monday, November 15, 9:30-9:55 AM ET

Live webcasts of the presentations will be accessible via Caribou's website on the Events page. Archived copies of the webcasts will be available on the Caribou website for 30 days after the events.